Evidence map›Paper›PMID 31771262›Full record

ArticleInternational journal of environmental research and public health2019

Early Waning of Maternal Measles Antibodies in Infants in Zhejiang Province, China: A Comparison of Two Cross-Sectional Serosurveys.

Ka Chun Chong, Yan Rui, Yan Liu, Tianyuan Zhou, Katherine Jia, Maggie Haitian Wang, Kirran N Mohammad, Hanqing He

Abstract readComparative Study
In one paragraph

Article in International journal of environmental research and public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ka Chun ChongSchool of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.ORCID 0000-0001-5610-1298
Yan RuiZhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310058, China.
Yan LiuSchool of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Tianyuan ZhouSchool of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Katherine JiaSchool of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Maggie Haitian WangSchool of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Kirran N MohammadSchool of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Hanqing HeZhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310058, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In China, children aged <8 months, who were expected to be protected by maternal antibodies before receiving the first dose of measles vaccine, were the age group with the greatest risk of infection in recent years. In this study, we evaluated whether infants yet to be age-eligible for measles vaccine had a sufficient seropositive level of maternal measles antibodies in 2009 and 2013. Blood samples were collected from infants aged <8 months through population-based serological surveys conducted in Zhejiang, China. Serum levels of immunoglobulin G measles antibodies were quantified using enzyme-linked immunosorbent assay. In 2013, the mean geometric mean titres (GMTs) of infants aged 4 to 8 months were below the seropositivity threshold (<200 mIU/mL), decreasing from 118.6 mIU/mL (95% confidence interval [CI] 83.0, 169.3 mIU/mL) at 4 months to 28.6 mIU/mL (95% CI 15.6, 52.3 mIU/mL) at 7 months. Antibody levels were significantly lower in 2013 than in 2009 starting from 5 months of age. In conclusion, infants aged 4 to 8 months are susceptible to measles due to low levels of maternal measles antibodies. It is thus suggested to provide infants with a supplementary dose on top of the routine schedule, and/or launch catch-up vaccination campaigns among young women.

Indexed as

Maternal ExposureAntibodies, ViralChinaCross-Sectional StudiesFemaleHumansInfantInfant, NewbornMeaslesSerologic TestsAntibodies, ViralChinainfantsmaternalmeaslesMVserosurveyvaccinewaning

Identifiers

PMID31771262
PMCPMC6926550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.